Skip to main content
02-2003-0802Administrative - FormalClosedFY 2003· Region 02

EPA v. Roche Vitamins, Inc.

Source Agrees

Case summary

On October 1, 2002, Roche submitted a voluntary disclosure pursuant to the Audit Policy, stating that they had failed to file EPCRA Form R Toxic Release Inventory Reports for nitrate compounds for calendar years 1995-2001. The Form R reports were submitted to the EPA on November 22, 2002. Upon review, it was determined that Roche did not meet Condition D.1 of the Audit Policy, Systematic Discovery. However, the disclosure did meet all the remaining conditions and Roche was therefore offered a 75% gravity penalty reduction for the violations, as provided under the Audit Policy. A CAFO (Docket number EPCRA 02-2003-4118) was subsequently executed on 7/7/03 for $21,544.

Defendants (1)

  • Roche Vitamins, Inc.Named in settlement

Facilities (1)

  • ROCHE VITAMINS, INC.

    206 ROCHE DRIVE, BELVIDERE, NJ, 078231113

    Registry ID: 110040963286

Statutes cited

  • EPCRA 313Toxic Chemical Release Reporting (TRI)

Enforcement conclusions (1)

  • Roche Vitamins, Inc. Roche Vitamins, Inc.entered 2003-05-22

    Primary law: EPCRA

Timeline (3 milestones)

  • 2003-05-22Enforcement Action Closed
  • 2003-05-22Final Order Issued
  • 2003-07-14Enforcement Action Data Entered

Case metadata

EPA activity ID
99079
Case number
02-2003-0802
Lead agency
EPA
Branch
WTS
EPA region
02
Voluntary self-disclosure
Yes
Primary statute
Toxic Chemical Release Reporting (TRI)

Sourced verbatim from EPA ECHO Enforcement Case Report for case 02-2003-0802 . Bulk data: ICIS-FEC download summary.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.